Arrowhead Pharmaceuticals Inc. buy Sumitomo Mitsui Financial Group, Inc.
Start price
26.04.23
/
50%
€30.42
Target price
26.04.24
€72.10
Performance (%)
-32.54%
End price
27.04.24
€20.52
Summary
This prediction ended on 27.04.24 with a price of €20.52. The BUY prediction by Sumitomo_Mitsui_Fina for Arrowhead Pharmaceuticals Inc. performed very badly with a performance of -32.54%. Sumitomo_Mitsui_Fina has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 6.698% | 6.698% | 449.238% | - |
| iShares Core DAX® | -1.741% | 5.979% | 8.977% | |
| iShares Nasdaq 100 | 2.815% | 11.827% | 38.406% | |
| iShares Nikkei 225® | -0.109% | 11.692% | 46.680% | |
| iShares S&P 500 | 0.966% | 7.616% | 28.141% |
Comments by Sumitomo_Mitsui_Fina for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is now covered by analysts at Sumitomo Mitsui Financial Group, Inc.. They set an "outperform" rating and a $80.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
In the thread Trading Arrowhead Pharmaceuticals Inc.
Die von Sumitomo_Mitsui_Fina gewählte maximale Laufzeit wurde überschritten